S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NASDAQ:KINS

Kingstone Companies (KINS) Stock Price, News & Analysis

$4.02
+0.03 (+0.75%)
(As of 04/19/2024 ET)
Today's Range
$3.93
$4.10
50-Day Range
$3.02
$4.67
52-Week Range
$1.04
$4.75
Volume
33,980 shs
Average Volume
21,951 shs
Market Capitalization
$44.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.75

Kingstone Companies MarketRank™ Stock Analysis

Analyst Rating
Sell
1.00 Rating Score
Upside/​Downside
56.5% Downside
$1.75 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.24mentions of Kingstone Companies in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.01 out of 5 stars

Finance Sector

845th out of 845 stocks

Fire, Marine, & Casualty Insurance Industry

51st out of 51 stocks

KINS stock logo

About Kingstone Companies Stock (NASDAQ:KINS)

Kingstone Companies, Inc., through its subsidiary, provides property and casualty insurance products to individuals in the United States. It offers personal line of insurance products, such as homeowners and dwelling fire, cooperative/condominiums, renters, and personal umbrella policies. The company also provides for-hire vehicle physical damage only policies for livery and car service vehicles and taxicabs; and canine legal liability policies. In addition, it offers reinsurance products. The company underwrites its products through retail and wholesale agents and brokers. The company was formerly known as DCAP Group, Inc. and changed its name to Kingstone Companies, Inc. in July 2009. Kingstone Companies, Inc. was founded in 1886 and is headquartered in Kingston, New York.

KINS Stock Price History

KINS Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Q4 2023 Kingstone Companies Inc Earnings Call
Here's what Wall Street expects from Kingstone Companies's earnings
Kingstone CEO Letter to Shareholders
Kingstone Completes Quota Share Placement
Kingstone Companies Inc KINS
See More Headlines
Receive KINS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kingstone Companies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2021
Today
4/19/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Fire, marine, & casualty insurance
Sub-Industry
N/A
Current Symbol
NASDAQ:KINS
Employees
84
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.75
High Stock Price Target
$1.75
Low Stock Price Target
$1.75
Potential Upside/Downside
-56.5%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

Net Income
$-6,170,000.00
Pretax Margin
-5.11%

Debt

Sales & Book Value

Annual Sales
$144.19 million
Book Value
$3.21 per share

Miscellaneous

Free Float
9,863,000
Market Cap
$44.26 million
Optionable
Optionable
Beta
0.59
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. Barry B. Goldstein (Age 71)
    Executive Chairman of the Board
    Comp: $472.2k
  • Ms. Meryl S. Golden (Age 64)
    President, CEO, COO & Director
    Comp: $525.2k
  • Ms. Sarah Chen (Age 41)
    Chief Actuary & Senior VP of Kingstone Insurance Company
    Comp: $355.34k
  • Mr. Floyd R. Tupper (Age 69)
    Secretary & Independent Director
    Comp: $75k
  • Ms. Jennifer Lee Gravelle (Age 52)
    VP, CFO & Treasurer
  • Mr. David Fernandez
    Senior VP & Chief Claims Officer

KINS Stock Analysis - Frequently Asked Questions

Should I buy or sell Kingstone Companies stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kingstone Companies in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" KINS shares.
View KINS analyst ratings
or view top-rated stocks.

What is Kingstone Companies' stock price target for 2024?

1 Wall Street research analysts have issued 1-year price objectives for Kingstone Companies' stock. Their KINS share price targets range from $1.75 to $1.75. On average, they predict the company's share price to reach $1.75 in the next twelve months. This suggests that the stock has a possible downside of 56.5%.
View analysts price targets for KINS
or view top-rated stocks among Wall Street analysts.

How have KINS shares performed in 2024?

Kingstone Companies' stock was trading at $2.13 at the beginning of the year. Since then, KINS shares have increased by 88.7% and is now trading at $4.02.
View the best growth stocks for 2024 here
.

When is Kingstone Companies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our KINS earnings forecast
.

How were Kingstone Companies' earnings last quarter?

Kingstone Companies, Inc. (NASDAQ:KINS) issued its earnings results on Thursday, November, 11th. The insurance provider reported ($1.02) EPS for the quarter, missing the consensus estimate of ($0.47) by $0.55. The insurance provider had revenue of $38.96 million for the quarter, compared to analysts' expectations of $39.61 million. Kingstone Companies had a negative net margin of 4.28% and a negative trailing twelve-month return on equity of 24.86%. During the same period in the previous year, the business earned ($0.27) EPS.

What guidance has Kingstone Companies issued on next quarter's earnings?

Kingstone Companies updated its FY 2024 earnings guidance on Wednesday, March, 27th. The company provided EPS guidance of 0.500-0.900 for the period. The company issued revenue guidance of -.

What is Barry B. Goldstein's approval rating as Kingstone Companies' CEO?

1 employees have rated Kingstone Companies Chief Executive Officer Barry B. Goldstein on Glassdoor.com. Barry B. Goldstein has an approval rating of 100% among the company's employees. This puts Barry B. Goldstein in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Kingstone Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kingstone Companies investors own include Navigators Group (NAVG), Bank of America (BAC), Intelsat (I), AMC Entertainment (AMC), Fossil Group (FOSL), Apollo Global Management (APO), Cypress Semiconductor (CY), Glu Mobile (GLUU), Great Panther Mining (GPL) and China Unicom (Hong Kong) (CHU).

How do I buy shares of Kingstone Companies?

Shares of KINS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KINS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners